March 5, 20260 citationsOpen Access
View Full PaperLocal prevalence and management of Janus kinase inhibitor-induced acne among adolescents with inflammatory bowel disease.
Key Points
- This research aims to explore the prevalence and management of acne resulting from Janus kinase inhibitors in adolescents with inflammatory bowel disease.
- Conducted a single-center cohort study
- Analyzed referral and treatment patterns for acne
- Evaluated the diversity in management approaches
- Acne was frequently reported among pediatric patients using JAKi for IBD
- Referral and treatment practices varied significantly
- Findings suggest a need for multidisciplinary management approaches
Abstract
In this single-center cohort study, acne was a common adverse event among pediatric patients taking JAKi for IBD. Referral and treatment patterns in our cohort varied greatly, which demonstrates the need for a multidisciplinary approach and larger prospective studies to discern the prevalence, characteristics, and treatment response of JAKi-induced acne to inform risks and benefits.
Cite This Study
Barclay et al. (Thu,) studied this question.